PTC Inc (PTC) 2026 stock outlook covering the Creo-Windchill-ThingWorx digital thread, why net-new ARR now drives the stock more than headline revenue, competition from Siemens and Dassault, and manufacturing capex cycle risk.
Masimo (MASI) 2026 stock outlook. A deep look at the SET pulse oximetry moat, the razor-and-blade sensor model, the Sound United misstep, the Politan activist campaign and governance reset, and the Apple Watch ITC patent win.
ST Pharm (237690) 2026 stock outlook. A deep qualitative look at its world-leading oligonucleotide CDMO position, RNA-drug demand from inclisiran, siRNA and GLP-1-adjacent pipelines, Dong-A Socio group backing, and the capacity-expansion cycle that drives the shares.
Viatris (VTRS) 2026 stock outlook. A qualitative deep dive into the Pfizer Upjohn-Mylan merger, the debt paydown and dividend story, brand-revenue decline offset by complex generics and biosimilars, EpiPen's fading pricing power, and the key risks.
Cencora (COR, formerly AmerisourceBergen) 2026 stock analysis: the big-three pharma distribution oligopoly, razor-thin margins on enormous volume, specialty and GLP-1 tailwinds, opioid settlement drag, and Walgreens customer concentration risk.
HanAll Biopharma (009420) 2026 stock outlook. A deep qualitative look at the batoclimab FcRn autoimmune franchise, the Immunovant and Harbour BioMed out-licensing royalty and milestone structure, the tanfanercept dry-eye pipeline, Daewoong group synergy, clinical catalysts, and the risks a US investor should weigh.
MarketAxess (MKTX) 2026 stock analysis: the RFQ and Open Trading network effect, how its basis-point fee model actually works, the Tradeweb share battle, portfolio trading risk, and where the growth runway still exists.
BLDR (Builders FirstSource) 2026 stock outlook. A deep, qualitative look at the largest US building-materials distributor: fragmented-market roll-up M&A, prefab and value-added margin expansion, single-family housing-starts and rate sensitivity, lumber-price swings, and aggressive buybacks shrinking the float.
Boryung (003850) 2026 stock outlook. A deep, qualitative look at Korea's homegrown Kanarb antihypertensive franchise (Duokarb, Dukaro), the Legacy Brands Acquisition cash roll-up strategy, the Axiom Space optionality bet, drug-price and generic risk, and how foreign investors should frame a Korean mid-cap pharma.
Raymond James Financial (RJF) 2026 stock analysis: the independent advisor moat, net interest income exposure to falling rates, cash sorting risk, advisor recruiting economics, the TriState Capital deal, and how RJF stacks up against LPL and Schwab.
Casey's General Stores (CASY) 2026 stock analysis: how a Midwest rural convenience-store chain turns thin fuel margins into a scratch-made pizza and prepared-food profit engine, its build-plus-acquire unit growth model, EV transition risk, and how it stacks up against 7-Eleven and Circle K.
Jeisys Medical (287410) 2026 stock outlook. A deep qualitative look at its RF and HIFU energy-based devices, the recurring consumable-tip revenue model, POTENZA export momentum, the three-way fight with Classys and Wontech, ownership and M&A risk, and the metrics that actually move this KOSDAQ aesthetic name.
NRG Energy (NYSE: NRG) stock outlook for 2026. A deep, qualitative look at the retail electricity and Vivint smart-home subscription engine, competitive generation, AI data-center power demand re-rating dispatchable capacity, aggressive buybacks, and commodity, weather, and leverage risk.
Tractor Supply Company (TSCO) 2026 stock outlook: the small-town real estate moat, the C.U.E. consumables model, Petsense and in-store vet clinic expansion, weather-driven seasonality, and farm-income cycle risk explained qualitatively.
T'way Air (KOSPI 091810) 2026 stock outlook. An in-depth look at why a Korean low-cost carrier is flying long-haul to Europe and Australia, the Korean Air-Asiana merger windfall, the Daemyung Sono ownership fight, and the fuel, FX, and aircraft-lease risks that define the thesis.
Pentair (PNR) 2026 stock analysis: how pool equipment, residential water filtration, and municipal flow control combine in one company, the Hydra-Stop and Manitowoc Ice bolt-on acquisitions, a 48-year dividend growth streak, and the housing-cycle risk investors underweight.
Hyosung TNC (298020) 2026 stock outlook. A deep look at CREORA spandex global #1 pricing power, bio-based spandex and regen recycled-fiber premium, versus PTMEG/BDO raw-material costs, Chinese capacity additions, and apparel-demand cycles for the US investor.
DL E&C (KOSPI 375500) 2026 stock outlook. A deep qualitative look at the ACRO and e-Pyeonhansesang housing brands, cost-to-completion and real-estate PF risk, and the pivot into overseas plant EPC, carbon capture (CCUS), hydrogen, and SMR, plus the low-valuation and shareholder-return debate.
Korea Investment Holdings (071050) stock outlook for 2026: how Korea Investment & Securities' brokerage, IB, and WM engine works alongside its Kakao Bank stake, the holding-company discount, and rate and volume cycle risk.
Pulmuone (KOSPI 017810) 2026 stock analysis: the #1 Korean fresh-food brand in tofu, bean sprouts, and fresh noodles, its structurally thin operating margins, imported-soybean and FX cost pressure, the Nasoya US tofu turnaround, plant-based expansion, and how it stacks up against CJ CheilJedang, Ottogi, Nongshim, and Daesang.
S-1 Corporation (012750) 2026 stock outlook: Korea's largest physical security operator, its subscription-style rental revenue moat, the margin drag from facility management, AI video security and unmanned-store upside, and the SK Shieldus rivalry.
Hana Tour (039130) 2026 stock outlook. A qualitative deep dive into Korea's top travel wholesaler: its nationwide agency-network moat, the post-Covid ownership shift to private equity firm IMM PE, mounting OTA competition, won/dollar exposure, and jet-fuel-linked airline capacity risk.
RFHIC (KOSDAQ 218410) 2026 stock outlook. A deep qualitative look at its GaN RF transistor and power amplifier business tied to 5G base stations, customer concentration in Samsung and Nokia, the pivot into defense RF and SiC power semiconductors, and competition from Wolfspeed, Qorvo and MACOM.
A qualitative deep dive into the Dongkuk Steel (460860) stock outlook for 2026, covering the 2023 spin-off from holding company Dongkuk Holdings and sister firm Dongkuk CM, its plate and section-steel product mix, electric arc furnace economics, construction-cycle and Chinese oversupply risk, post-split capital allocation, and how Korea-stock taxation works for foreign investors.